Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
4
×
celgene
4
×
detroit blog main
detroit top stories
fda
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
eli lilly
johnson & johnson
pfizer
acquisition
allergan
astrazeneca
avexis
clinical trials
genentech
What
bio
roundup
celgene
days
fda
news
airport
annual
apocalypse
approved
august
beds
biopharma
biotech
busy
car
colleagues
companies
decisions
devices
digital
disease
drug
drugs
epidemic
exome
fallout
fatty
frenzied
gone
government
growing
health
home
hundreds
industry
j.p
jpm
known
led
Language
unset
Current search:
celgene
×
fda
×
" bristol-myers squibb "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
